As Samsung Biologics works to close a massive buyout to branch out into peptides, the Korean CDMO’s bread-and-butter contracting work continues to gin up big-ticket contracts from the drug industry.
Samsung Bio, waiting to break into peptides, nets $262M manufacturing deal with unnamed EU pharma
Latest from Blog
Oz says ‘AI-based avatars’ can help rural communities. Some leaders disagree
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. A high-level official at Anthropic posted on Tuesday evening that he believes there is
STAT+: Five midterm races to watch that could be crucial for vaccine policy
In Iowa, the Republican candidate for governor wants to end all school vaccine requirements. In Florida, the Republican running for governor recently told CBS that he supported his state’s push to remove
Coroner releases details of infants who died amid growing Pennsylvania measles outbreak
NEW YORK — The two measles-related deaths in Pennsylvania last month involved infants, and the virus itself caused one of the deaths, a Pennsylvania coroner confirmed Wednesday. Lancaster County’s coroner, Dr. Stephen Diamantoni, said
Texas Releases Its First-Ever Official Nutrition Guidelines
The Texas Nutrition Advisory Committee today published the first nutritional guidelines created by Texans for Texans. Post Views: 1
New Food Farmacy Brings Fresh Food and Nutrition Support to Long Branch Patients
LONG BRANCH, N.J. — Monmouth Medical Center has opened a new Food Farmacy that will provide patients with nutritious food, nutrition counseling and educational resources focused on chronic disease… Post Views: 2